GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $67,000 | +86.1% | 310 | 0.0% | 0.00% | – |
| Q4 2020 | $36,000 | +20.0% | 310 | 0.0% | 0.00% | – |
| Q3 2020 | $30,000 | -21.1% | 310 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $38,000 | +40.7% | 310 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $27,000 | -15.6% | 310 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | -11.1% | 310 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $36,000 | -32.1% | 310 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $53,000 | +1.9% | 310 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $52,000 | +73.3% | 310 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $30,000 | -48.3% | 310 | -7.2% | 0.00% | 0.0% |
| Q3 2018 | $58,000 | +16.0% | 334 | -7.2% | 0.00% | 0.0% |
| Q2 2018 | $50,000 | +42.9% | 360 | +16.1% | 0.00% | 0.0% |
| Q1 2018 | $35,000 | -18.6% | 310 | -4.6% | 0.00% | 0.0% |
| Q4 2017 | $43,000 | +30.3% | 325 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $33,000 | 0.0% | 325 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | -17.5% | 325 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $40,000 | +14.3% | 335 | +8.1% | 0.00% | 0.0% |
| Q4 2016 | $35,000 | +25.0% | 310 | +47.6% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | +47.4% | 210 | 0.0% | 0.00% | – |
| Q2 2016 | $19,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | +26.7% | 210 | 0.0% | 0.00% | – |
| Q4 2015 | $15,000 | -21.1% | 210 | 0.0% | 0.00% | – |
| Q3 2015 | $19,000 | -26.9% | 210 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $26,000 | +36.8% | 210 | 0.0% | 0.00% | – |
| Q1 2015 | $19,000 | +35.7% | 210 | 0.0% | 0.00% | – |
| Q4 2014 | $14,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|